The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...

Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban ...

Illumina (NASDAQ ... It also said it is instituting a $100 million cost reduction program for fiscal 2025. "Our new fiscal 2025 guidance provides for limited further earnings contribution from ...

China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina , just minutes ...

Health care giant Roche announced its plans recently for a new kind of sequencing analysis ... could lose more than $100 ...

Illumina has been barred from exporting its DNA sequencers to China, which closed | Illumina has been barred from exporting ...

China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory measures against fresh US tariffs on all Chinese goods, deepening the US company’s woes in one ...

Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.

China Bans Imports of Illumina's Gene Sequencers Right After Trump Tariff Action By Andrew Silver SHANGHAI (Reuters) -China announced a ban on Tuesday on imports of genetic sequencers from U.S ...